The incidence of IFD is relatively higher in allo-HSCT recipients (7.4%–13.1%) and has shown an increasing trend annually.
← all excerpts
Case Report: A pharmacist-led precision therapy framework for managing invasive fungal infection in CSF1R-Related leukoencephalopathy post Allo-HSCT.
1
—
—